75 related articles for article (PubMed ID: 6368327)
1. [Methergoline in the treatment of prolactinemia in women].
Radowicki S
Ginekol Pol; 1983; 54(11-12):729-35. PubMed ID: 6368327
[No Abstract] [Full Text] [Related]
2. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
3. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases].
Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C
Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283
[No Abstract] [Full Text] [Related]
4. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
[No Abstract] [Full Text] [Related]
5. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
[No Abstract] [Full Text] [Related]
6. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
[TBL] [Abstract][Full Text] [Related]
7. Metergoline as an inhibitor of prolactin release.
Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
[TBL] [Abstract][Full Text] [Related]
8. [Antilactogenic activity of methergoline. Blocking of lactation and inhibition of prolactin secretion in the postpartum period].
Delitala G; Lodico G; Stoppelli I
Minerva Ginecol; 1977 May; 29(5):359-68. PubMed ID: 896082
[No Abstract] [Full Text] [Related]
9. [Methergoline in the prevention and interruption of puerperal lactation: a multicenter clinico-biological study].
Bareggi SR; Pellicciotta G; Pontiroli AE; Pollini C; Praga C
Farmaco Prat; 1982 Mar; 37(3):98-108. PubMed ID: 7040101
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
Schneider WH; Huber H; Spona J
Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
[TBL] [Abstract][Full Text] [Related]
11. Metergoline treatment of hyperprolactinemic states.
Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E
Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408
[No Abstract] [Full Text] [Related]
12. Intolerance of bromocriptine: is metergoline a satisfactory alternative?
Casson IF; Walker BA; Hipkin LJ; Belchetz PE
Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1783-4. PubMed ID: 3924253
[No Abstract] [Full Text] [Related]
13. Metergoline in the management of normoprolactinemic secondary amenorrhea. A multicentric controlled trial.
Fadini R; Meschia M; Crosignani PG; Falsetti L; Vignali M; Ferla P; Cavagnini F; Pinto M; Travaglini P; Faglia
Gynecol Obstet Invest; 1984; 17(1):47-53. PubMed ID: 6368332
[TBL] [Abstract][Full Text] [Related]
14. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
Falsetti L; Scagliola P; Turla R; Voltolini AM
Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
[TBL] [Abstract][Full Text] [Related]
15. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
16. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
[TBL] [Abstract][Full Text] [Related]
17. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with metergoline in patients with idiopathic oligospermia.
Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP
Clin Endocrinol (Oxf); 1979 Sep; 11(3):349-52. PubMed ID: 509746
[TBL] [Abstract][Full Text] [Related]
19. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
Holtkamp W; Nagel GA
Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on the use of methergoline for the inhibition of lactation during the puerperium].
Giana M; Dolfin G; Siliquini G
Minerva Med; 1979 Nov; 70(49):3337-41. PubMed ID: 503350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
